Vocal Biomarkers Market Expected to Secure Notable Revenue Share During 2019 to 2028

Press Release

Latest Industry Research Report On “Vocal Biomarkers – Industry Pipeline Insight, 2019” in-depth analysis of the market state and also the competitive landscape globally.

“Vocal Biomarkers – Industry Pipeline Insight, 2019” – the report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vocal Biomarkers development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Request Sample Copy of Research @

Below is the Short Brief of the Vocal Biomarkers Market Report:

Sound vibrations are used as part of therapeutic healing for various mental health conditions such as depression and anxiety. Recent research studies, however, have greatly broadened its application into diagnosis of diseases. Biomarkers in the voice of a person have been linked to disorders such as depression, coronary artery disease, and anxiety. On successful completion of clinical trials, HIPAA compliant vocal biomarker system would serve as much more effective alternative to current diagnostic techniques such as MRI, X-Ray, and CT scan. Research is also underway for identifying vocal biomarkers in diagnosis of Parkinson’s disease, traumatic brain injury, cognitive impairment, and respiratory disorders, which would open up a highly lucrative avenue for growth for players in this industry. Companies dealing with voice technology are sampling data to provide accurate results. For instance, Beyond Verbal, Inc. has been researching on vocal biomarkers since 1996, and has collected over 2.5 million voice samples in over 40 different languages.

While currently in its very nascent stage with an estimated value of US$ 6.4 million in 2017, the global vocal biomarkers market is expected to expand at a CAGR of 65.7% during the forecast period (2017 – 2028).

Descriptive coverage of pipeline development activities for Vocal Biomarkers

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies, and patent details.

Pipeline Therapeutics assessment of products for Vocal Biomarkers

The report assesses the active Vocal Biomarkers pipeline products by developmental stage, product type, molecule type, and administration route.

Regional Segmentation:

For further clarification, analysts have also segmented the market on the basis of geography. This type of segmentation allows the readers to understand the volatile political scenario in varying geographies and their impact on the Global Vocal Biomarkers Market. On the basis of geography, the global market has been segmented into:

North America: United States, Canada, Mexico

Europe: Germany, France, UK, Russia, Italy, Rest of Europe

Middle East Africa: Turkey, Egypt, South Africa, GCC Countries, Rest of Middle East & Africa

Asia-Pacific: China, India, Australia, Japan, South Korea, Indonesia, Malaysia, Philippines, Thailand, Vietnam

Key Competitors:

The prominent companies in the Vocal Biomarkers Market are represented to offer an entire overview of their strategies of growth, standing in finance, product and services pipeline, as well as recent collaborations and developments. At the company level, this report focuses on the production capacity, ex-factory price, revenue, and market share for each manufacturer covered in this report. It gives focus on the dynamic and static view of the Market, which promotes the way to decide the working framework of the industries. Different leading global competitors are analyzed and give a clear vision of the competition at domestic as well as global level.

Key companies covered as a part of this study include Beyond Verbal, Inc., Cogito Corporation, Sonde Health, Sharecare, Inc., and IBM Corporation

A detailed segmentation evaluation and growth prospects of the market have been included in the report. The forecast of volume and revenue shares along with Vocal Biomarkers market witnesses are provided in the report.


Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by a team of industry experts.

Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Look Insights Of Global Vocal Biomarkers Market Research Report @

Scope of the report:

  • The report provides a snapshot of the pipeline development for the Vocal Biomarkers
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Vocal Biomarkers
  • The report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Vocal Biomarkers
  • The report also covers the dormant and discontinued pipeline projects related to the Vocal Biomarkers

Reasons to Buy:

  • Establish a comprehensive understanding of the pipeline activity across this Vocal Biomarkers to formulate effective R&D strategies
  • Gather information of the emerging competitors having a potentially lucrative portfolio in this space and create effective counter-strategies to gain competitive advantage
  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Vocal Biomarkers therapeutics
  • Devise in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Order a Copy of Global Vocal Biomarkers Market Report 2019 @

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This post was originally published on Trading Herald

RSS news